News
Media
Conferences
Publication
Job Board
CME/CE
Partners
Editorial
Resources
Subscribe

Spotlight -

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|

Major Depressive Disorder

News|Articles|September 21, 2023

World Alzheimer's Day 2023

Author(s)Psychiatric Times Editors

Today is World Alzheimer's Day!

Newsletter

Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.

Related Content

Alzheimer

Phase 2 MINDFul Trial Results on XPro1595 for Early Alzheimer Disease With Inflammation

May 15th 2026

Blocking Toxic Oligomers: The Science and Strategy Behind Zervimesine

Blocking Toxic Oligomers: The Science and Strategy Behind Zervimesine

ByAnthony Caggiano, MD, PhD

May 11th 2026

Slowing Progression With Zervimesine in Dementia With Lewy Bodies

Slowing Progression With Zervimesine in Dementia With Lewy Bodies

ByAnthony Caggiano, MD, PhD

May 8th 2026

pipeline

Psychiatry’s Medication Pipeline in Motion

ByJohn J. Miller, MD

May 7th 2026

Agitation in Alzheimer Disease Dementia: Practical Insights for Clinicians

Agitation in Alzheimer Disease Dementia: Practical Insights for Clinicians

ByRajesh R. Tampi, MD, MS, DFAPA, DFAAGP

May 4th 2026

Latest CME

Southern California Psychiatry Conference

In-Person Event

Southern California Psychiatry Conference

July 10-11, 2026

(CME Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

(CME Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Gus Alva, MD, DFAPA; Ilan Melnick, MD

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Jason Kellogg, MD; Gus Alva, MD, DFAPA; Melanie Barrett, MD; Yvette Elpidio, MSN, FNP-C

Trending on Psychiatric Times

FDA Issues CRL for CTx-1301 for Treatment of ADHD

Insights Into Mechanism-Based Biomarkers for Psychosis Prediction from Kim Do, PhD

Endangered Education: Psychiatric Professional Degrees Under Attack

New Name, New Path for Psychiatry: The Future of the DSM

Nonpharmacological Augmentation of Ketamine, Neuroplasticity, and Behavioral Therapy